Global CHO Cell Line Development Service Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10245608

Publication Date:

November 1, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

CHO Cell Line Development Service is a professional service for biopharmaceutical companies and research institutions to develop Chinese Hamster Ovary (CHO) cell lines. CHO cells are one of the main mammalian cell lines used to produce therapeutic proteins such as monoclonal antibodies, recombinant proteins and vaccines. The service includes the entire process from gene cloning to stable cell line development, production optimization and scale-up to ensure that the required biologics can be produced efficiently and at high yield.
The global CHO Cell Line Development Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淐HO Cell Line Development Service Industry Forecast鈥� looks at past sales and reviews total world CHO Cell Line Development Service sales in 2022, providing a comprehensive analysis by region and market sector of projected CHO Cell Line Development Service sales for 2023 through 2029. With CHO Cell Line Development Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CHO Cell Line Development Service industry.
This Insight Report provides a comprehensive analysis of the global CHO Cell Line Development Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CHO Cell Line Development Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global CHO Cell Line Development Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CHO Cell Line Development Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CHO Cell Line Development Service.
United States market for CHO Cell Line Development Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for CHO Cell Line Development Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for CHO Cell Line Development Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key CHO Cell Line Development Service players cover Sartorius, GTP Bioways, Selexis, Samsung Biologics, Hera BioLabs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of CHO Cell Line Development Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gene Cloning and Transfection
Cell Culture Optimization
Others
Segmentation by Application:
Biopharmaceutical Production
Vaccine Development
Gene Therapy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Gene Cloning and Transfection
Cell Culture Optimization
Others
Segmentation by Application:
Biopharmaceutical Production
Vaccine Development
Gene Therapy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sartorius
GTP Bioways
Selexis
Samsung Biologics
Hera BioLabs
Abzena
FyoniBio
WuXi Biologics
DiscoverX
GenScript

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CHO Cell Line Development Service Market Size 2019-2030
2.1.2 CHO Cell Line Development Service Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for CHO Cell Line Development Service by Country/Region, 2019, 2023 & 2030
2.2 CHO Cell Line Development Service Segment by Type
2.2.1 Gene Cloning and Transfection
2.2.2 Cell Culture Optimization
2.2.3 Others
2.3 CHO Cell Line Development Service Market Size by Type
2.3.1 CHO Cell Line Development Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global CHO Cell Line Development Service Market Size Market Share by Type (2019-2024)
2.4 CHO Cell Line Development Service Segment by Application
2.4.1 Biopharmaceutical Production
2.4.2 Vaccine Development
2.4.3 Gene Therapy
2.4.4 Others
2.5 CHO Cell Line Development Service Market Size by Application
2.5.1 CHO Cell Line Development Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global CHO Cell Line Development Service Market Size Market Share by Application (2019-2024)
3 CHO Cell Line Development Service Market Size by Player
3.1 CHO Cell Line Development Service Market Size Market Share by Player
3.1.1 Global CHO Cell Line Development Service Revenue by Player (2019-2024)
3.1.2 Global CHO Cell Line Development Service Revenue Market Share by Player (2019-2024)
3.2 Global CHO Cell Line Development Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CHO Cell Line Development Service by Region
4.1 CHO Cell Line Development Service Market Size by Region (2019-2024)
4.2 Global CHO Cell Line Development Service Annual Revenue by Country/Region (2019-2024)
4.3 Americas CHO Cell Line Development Service Market Size Growth (2019-2024)
4.4 APAC CHO Cell Line Development Service Market Size Growth (2019-2024)
4.5 Europe CHO Cell Line Development Service Market Size Growth (2019-2024)
4.6 Middle East & Africa CHO Cell Line Development Service Market Size Growth (2019-2024)
5 Americas
5.1 Americas CHO Cell Line Development Service Market Size by Country (2019-2024)
5.2 Americas CHO Cell Line Development Service Market Size by Type (2019-2024)
5.3 Americas CHO Cell Line Development Service Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CHO Cell Line Development Service Market Size by Region (2019-2024)
6.2 APAC CHO Cell Line Development Service Market Size by Type (2019-2024)
6.3 APAC CHO Cell Line Development Service Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CHO Cell Line Development Service Market Size by Country (2019-2024)
7.2 Europe CHO Cell Line Development Service Market Size by Type (2019-2024)
7.3 Europe CHO Cell Line Development Service Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CHO Cell Line Development Service by Region (2019-2024)
8.2 Middle East & Africa CHO Cell Line Development Service Market Size by Type (2019-2024)
8.3 Middle East & Africa CHO Cell Line Development Service Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CHO Cell Line Development Service Market Forecast
10.1 Global CHO Cell Line Development Service Forecast by Region (2025-2030)
10.1.1 Global CHO Cell Line Development Service Forecast by Region (2025-2030)
10.1.2 Americas CHO Cell Line Development Service Forecast
10.1.3 APAC CHO Cell Line Development Service Forecast
10.1.4 Europe CHO Cell Line Development Service Forecast
10.1.5 Middle East & Africa CHO Cell Line Development Service Forecast
10.2 Americas CHO Cell Line Development Service Forecast by Country (2025-2030)
10.2.1 United States Market CHO Cell Line Development Service Forecast
10.2.2 Canada Market CHO Cell Line Development Service Forecast
10.2.3 Mexico Market CHO Cell Line Development Service Forecast
10.2.4 Brazil Market CHO Cell Line Development Service Forecast
10.3 APAC CHO Cell Line Development Service Forecast by Region (2025-2030)
10.3.1 China CHO Cell Line Development Service Market Forecast
10.3.2 Japan Market CHO Cell Line Development Service Forecast
10.3.3 Korea Market CHO Cell Line Development Service Forecast
10.3.4 Southeast Asia Market CHO Cell Line Development Service Forecast
10.3.5 India Market CHO Cell Line Development Service Forecast
10.3.6 Australia Market CHO Cell Line Development Service Forecast
10.4 Europe CHO Cell Line Development Service Forecast by Country (2025-2030)
10.4.1 Germany Market CHO Cell Line Development Service Forecast
10.4.2 France Market CHO Cell Line Development Service Forecast
10.4.3 UK Market CHO Cell Line Development Service Forecast
10.4.4 Italy Market CHO Cell Line Development Service Forecast
10.4.5 Russia Market CHO Cell Line Development Service Forecast
10.5 Middle East & Africa CHO Cell Line Development Service Forecast by Region (2025-2030)
10.5.1 Egypt Market CHO Cell Line Development Service Forecast
10.5.2 South Africa Market CHO Cell Line Development Service Forecast
10.5.3 Israel Market CHO Cell Line Development Service Forecast
10.5.4 Turkey Market CHO Cell Line Development Service Forecast
10.6 Global CHO Cell Line Development Service Forecast by Type (2025-2030)
10.7 Global CHO Cell Line Development Service Forecast by Application (2025-2030)
10.7.1 GCC Countries Market CHO Cell Line Development Service Forecast
11 Key Players Analysis
11.1 Sartorius
11.1.1 Sartorius Company Information
11.1.2 Sartorius CHO Cell Line Development Service Product Offered
11.1.3 Sartorius CHO Cell Line Development Service Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sartorius Main Business Overview
11.1.5 Sartorius Latest Developments
11.2 GTP Bioways
11.2.1 GTP Bioways Company Information
11.2.2 GTP Bioways CHO Cell Line Development Service Product Offered
11.2.3 GTP Bioways CHO Cell Line Development Service Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GTP Bioways Main Business Overview
11.2.5 GTP Bioways Latest Developments
11.3 Selexis
11.3.1 Selexis Company Information
11.3.2 Selexis CHO Cell Line Development Service Product Offered
11.3.3 Selexis CHO Cell Line Development Service Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Selexis Main Business Overview
11.3.5 Selexis Latest Developments
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Information
11.4.2 Samsung Biologics CHO Cell Line Development Service Product Offered
11.4.3 Samsung Biologics CHO Cell Line Development Service Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Samsung Biologics Main Business Overview
11.4.5 Samsung Biologics Latest Developments
11.5 Hera BioLabs
11.5.1 Hera BioLabs Company Information
11.5.2 Hera BioLabs CHO Cell Line Development Service Product Offered
11.5.3 Hera BioLabs CHO Cell Line Development Service Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Hera BioLabs Main Business Overview
11.5.5 Hera BioLabs Latest Developments
11.6 Abzena
11.6.1 Abzena Company Information
11.6.2 Abzena CHO Cell Line Development Service Product Offered
11.6.3 Abzena CHO Cell Line Development Service Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abzena Main Business Overview
11.6.5 Abzena Latest Developments
11.7 FyoniBio
11.7.1 FyoniBio Company Information
11.7.2 FyoniBio CHO Cell Line Development Service Product Offered
11.7.3 FyoniBio CHO Cell Line Development Service Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 FyoniBio Main Business Overview
11.7.5 FyoniBio Latest Developments
11.8 WuXi Biologics
11.8.1 WuXi Biologics Company Information
11.8.2 WuXi Biologics CHO Cell Line Development Service Product Offered
11.8.3 WuXi Biologics CHO Cell Line Development Service Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 WuXi Biologics Main Business Overview
11.8.5 WuXi Biologics Latest Developments
11.9 DiscoverX
11.9.1 DiscoverX Company Information
11.9.2 DiscoverX CHO Cell Line Development Service Product Offered
11.9.3 DiscoverX CHO Cell Line Development Service Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 DiscoverX Main Business Overview
11.9.5 DiscoverX Latest Developments
11.10 GenScript
11.10.1 GenScript Company Information
11.10.2 GenScript CHO Cell Line Development Service Product Offered
11.10.3 GenScript CHO Cell Line Development Service Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GenScript Main Business Overview
11.10.5 GenScript Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂